Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with increased revenue, EBITDA, and cash flow, alongside strategic initiatives like the consolidation of institutions and redemption of preferred shares. Despite some operational risks and unclear guidance on certain aspects, the overall sentiment is positive due to improved profitability and strategic cost reductions. The anticipated savings from preferred share redemption and asset sales further bolster this outlook, suggesting a likely positive stock reaction.
Total Revenue $164,600,000, an increase of $10,100,000 or 6.6% from the prior year period, driven by increased revenue at Rasmussen, APUS, and Hondros.
Adjusted EBITDA $21,200,000, a $4,200,000 or 25% increase over the prior year, due to military registrations at APUS, student retention at Rasmussen, and timing of approximately $1,400,000 of expenses.
Net Income $7,500,000, compared to a net loss of $1,000,000 in the prior year, attributed to improved operating leverage and increased enrollment.
Adjusted EBITDA Margin 12.9%, expanded by nearly 200 basis points from 11% in the prior year, reflecting improved profitability.
Cash Flow from Operations $37,000,000, compared to $20,700,000 in the prior year, driven by the collection of tuition assistance accounts receivable at APUS and a reduction in operating losses at Rasmussen.
CapEx $3,900,000, compared to $6,200,000 in the prior year, indicating a decrease in capital expenditures.
Total Cash and Cash Equivalents $187,500,000, an increase of $28,600,000 from year-end 2024, reflecting improved cash flow from operations.
Net Income to Common Shareholders Increased by $500,000 from a negative $6,200,000 net loss in the prior year, due to improved profitability.
Rasmussen Adjusted EBITDA Positive $2,400,000, a swing from a negative $2,600,000 loss in the first quarter of twenty twenty-four, driven by increased enrollment.
Hondros Revenue $17,700,000, up 7.5% from the prior year, due to continued enrollment growth.
Graduate School Revenue $3,700,000, down from $4,200,000 in the prior year, impacted by government employee headcount reductions and uncertainty around future budgets.
Enrollment Growth at Rasmussen: Rasmussen's enrollment increased 7% in Q1 2025 and 8% in Q2 2025, marking the fourth consecutive quarter of year-over-year enrollment increases.
Enrollment Growth at Hondros: Hondros reported a 9.6% enrollment growth in Q1 2025 and a 13.5% increase in Q2 2025.
APUS Graduation Statistics: APUS conferred over 18,000 diplomas, with 66% of graduates being active duty military, veterans, or military spouses.
Adjusted EBITDA Guidance Increase: APEI raised its full year adjusted EBITDA guidance by $2,000,000 to a range of $77,000,000 to $87,000,000.
Cost Management: Improved operating leverage driven by increasing enrollment and disciplined cost management, resulting in a 25% increase in adjusted EBITDA.
Redemption of Preferred Shares: APEI plans to redeem its preferred shares by the end of Q2 2025, saving approximately $6,000,000 in annual dividend expenses starting in 2026.
Sale of Corporate Buildings: Two corporate buildings are expected to generate over $20,000,000 in net proceeds, anticipated to close in Q3 2025.
Consolidation of Institutions: APEI plans to combine its three degree-granting institutions into a single consolidated institution, expected to close by year-end 2025.
Focus on Nursing Programs: The consolidation will allow for expanded nursing programs at Hondros campuses, addressing the growing demand for nursing roles.
Regulatory Risks: Potential impacts from government shutdowns or changing federal and state government politics or policies, which could affect revenues or the timing of receivables.
Graduate School Challenges: Uncertainty around future budgets for training and professional development due to government employee headcount reductions and actions taken by the Department of Government Efficiency (Doge), which negatively impacts revenue guidance.
Enrollment Risks: While Rasmussen and Hondros are seeing positive enrollment growth, there is a risk associated with the Graduate School's declining enrollment and revenue.
Cost Management: Increased employee compensation and advertising costs are contributing to rising expenses, which could impact profitability if not managed effectively.
Market Competition: The company faces competitive pressures in the education sector, particularly in nursing and healthcare programs, which could affect enrollment and revenue.
Economic Factors: Potential economic downturns could impact enrollment trends, particularly in higher education, as students may reconsider their educational investments.
Operational Risks: Delays in the approval process for the consolidation of institutions could affect operational efficiency and financial performance.
Interest Expense: Higher interest expenses in Q2 due to the redemption premium associated with preferred stock, which could impact net income.
Adjusted EBITDA Guidance: Full year adjusted EBITDA guidance raised by $2,000,000 to a range of $77,000,000 to $87,000,000.
Net Income Guidance: Full year net income guidance increased to between $23,000,000 and $30,000,000.
Revenue Guidance: Maintaining full year revenue expectation of $650,000,000 to $660,000,000.
Preferred Stock Redemption: Intend to redeem preferred shares by the end of Q2, saving approximately $6,000,000 in annual dividend expenses starting in 2026.
Institution Consolidation: Plan to combine three degree-granting institutions into a single consolidated institution by year-end 2025.
Campus Closures and Sales: Closed underperforming campuses and expect to generate over $20,000,000 from the sale of two corporate buildings.
Q2 Revenue Guidance: Consolidated revenue expected to be between $160,000,000 and $162,000,000.
Q2 Adjusted EBITDA Guidance: Expected to be between $11,500,000 and $14,000,000.
Q2 Net Loss Guidance: Expected net loss available to common shareholders between $2,500,000 and $700,000.
CapEx Guidance: Full year CapEx guidance remains unchanged at $18,000,000 to $22,000,000.
Free Cash Flow Expectations: Expected free cash flow for the full year to be between $55,000,000 and $69,000,000.
Annual Dividend Savings: The redemption of preferred shares is expected to save approximately $6,000,000 in dividend expense annually beginning in 2026.
Redemption of Preferred Shares: The company intends to redeem all of its Series A senior preferred stock in the second quarter, which will reduce preferred dividend payments by approximately $3,000,000 in 2025.
Expected Proceeds from Asset Sales: The anticipated net proceeds from the sale of two corporate buildings are more than $20,000,000, expected to close in Q3 of 2025.
The earnings call revealed mixed sentiments. Strong enrollment growth and positive guidance for adjusted EBITDA and free cash flow are countered by a projected net loss in Q3 and concerns about APUS registration declines. Cost-saving measures and a lack of specific details on capacity growth and future profit impacts add uncertainty. Overall, the neutral sentiment reflects balanced positive and negative factors, with no clear catalyst for significant stock movement.
The earnings call shows strong financial metrics, such as increased EBITDA, cash flow, and unrestricted cash. Despite some negative aspects like reduced Graduate School revenue and unclear military funding distribution, the overall sentiment is positive. The consolidation plan, breakeven status of Rasmussen and Hondros, and increased guidance for EBITDA and net income further support this view. The Q&A reveals potential growth through consolidation and military enrollments, although some management responses lacked clarity. Overall, the positive aspects outweigh the negatives, suggesting a likely stock price increase.
The earnings call reveals strong financial performance with increased revenue, EBITDA, and cash flow, alongside strategic initiatives like the consolidation of institutions and redemption of preferred shares. Despite some operational risks and unclear guidance on certain aspects, the overall sentiment is positive due to improved profitability and strategic cost reductions. The anticipated savings from preferred share redemption and asset sales further bolster this outlook, suggesting a likely positive stock reaction.
The earnings call highlights strong financial performance with increased revenue, improved profitability, and expanded margins. Despite some uncertainties in graduate school guidance and consolidation synergies, the overall sentiment is bolstered by positive enrollment trends, especially in nursing, and strategic cost management. The Q&A section reveals confidence in handling potential challenges, such as the portal outage and economic cyclicality. With optimistic guidance and strategic initiatives, the stock is likely to experience a positive movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.